Anti-CD47
Antibody Market
Anti-CD47 Antibody Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Anti-CD47 Antibody Market Size and Growth
The Anti-CD47 Antibody market is experiencing significant growth, driven by increasing investments in cancer therapies and advancements in immunotherapy. Currently valued at approximately $1.1 billion, the market is projected to reach around $5.6 billion by 2030, reflecting a robust CAGR. Factors influencing market dynamics include novel drug development and expanding clinical trials. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ BosterBio
◍ Leinco Technologies
◍ Bioss
◍ Novus Biologicals
◍ Thermo Fisher Scientific
◍ Biorbyt
◍ Abbexa
◍ Bio X Cell
◍ GeneTex
◍ R&D Systems
◍ LSBio
◍ MyBioSource
◍ ProSci
◍ antibodies-online
◍ ABclonal Technology
◍ Abnova Corporation
◍ G Biosciences
The Anti-CD47 antibody market features companies like BosterBio and BioLegend, among others, providing diverse products for research in immunotherapy and cancer treatment. Their offerings enhance research capabilities, driving market growth. Sales figures include: BioLegend – ~$300M, Thermo Fisher Scientific – ~$25B, Bio-Rad – ~$3B, and GenTex – ~$10M.
◍ BioLegend
Request Sample Report
Market Segmentation
By Application
Biotechnology
Medical
University
Others
By Product
◍ Monoclonal Antibody
Polyclonal Antibody
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
